Preventive Action of Tranylcypromine on Alloxan Diabetes in Rats
- 1 November 1967
- journal article
- research article
- Published by American Diabetes Association in Diabetes
- Vol. 16 (11) , 810-812
- https://doi.org/10.2337/diab.16.11.810
Abstract
The intraperitoneal injection of tranylcypromine (25 mg/kg) 20 min before the intravenous administration of alloxan prevents the onset of diabetes in the rat. The same protective effect is observed when the monoamine-oxidase inhibitor is injected intravenously (10 mg/kg) 15 sec before alloxan. When these 2 drugs are mixed in vitro and injected intravenously, the protection disappears. This protective action against diabetes indicates that tranylcypromine protects important enzymatic centers against the action of alloxan at the pancreatic level.This publication has 4 references indexed in Scilit:
- Modification of the hypoglycaemic response to tolbutamide and insulin by mebanazine—an inhibitor of monoamine oxidaseJournal of Pharmacy and Pharmacology, 1965
- TREATMENT OF DIABETICS WITH MONOAMINE-OXIDASE INHIBITORSThe Lancet, 1964
- Inhibition of the Citric Acid Cycle by AlloxanJournal of Biological Chemistry, 1962
- Possible Relations of Hypoglycaemia Induced by Mono-amine Oxidase Inhibition and Angina Pectoris.Experimental Biology and Medicine, 1961